Topic Archives: Norilsk Nickel (NILSY)

Christian DeHaemer was an eager evangelist for “blood in the streets” investing many years ago, when we first started covering his hyped-up hints about earthshaking discoveries and — but it’s not the the Rothschild “buy when there’s blood in the streets” dictum, it’s quite a bit more literal. He has long talked of buying stocks […]

Comments

  • Avatar

    I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...

  • Travis Johnson, Stock Gumshoe

    Thanks, I didn’t run across the Boston presentation....

  • Avatar

    SGMO has lost nearly half it's value since late Aug., 2018! What has the market done since then??? NEXT!!!...

  • Avatar

    If SGMO had anything worth pursuing they would have been bought out by now. Wait until they get approval and start makin...

  • Avatar

    SGMO is down 34% at 1:30 EST. Down more at 11:30, but seem to have risen a little....

  • Avatar

    It is Sangamo Therapeutics ( SGMO )....

  • Avatar

    The ONLY gene editing stock to own is SGMO. No off targets unlike the rest. 7 readouts this year. Imo, will cure HIV ...

  • Avatar

    Does anyone own Sangamo Therapeutics. (SGMO) I should call myself the "Greenhorn" because I know virtually nothing about...

  • Avatar

    Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...

  • Avatar

    SGMO down 20% today looks like things didn't go so well: https://www.marketwatch.com/story/sangamo-stock-drops-13-pre...

  • Avatar

    Good results but shares drop 20% good spot from Travis, on the opportunity to buy as it happens that would seem to be t...

  • Travis Johnson, Stock Gumshoe

    Right, that's the dream of future possibility... but the first trial data is for a very small disease. Not unusual, jus...

  • Avatar

    Hi All , Sangamo are holding a conference call today just after the presentation in Greece, The call will follow the ...

  • Avatar

    https://www.fool.com/investing/2018/09/03/why-sangamo-therapeutics-shot-337-higher-in-august.aspx...

  • Avatar

    As usual - you got it right...:) Confirming its SGMO, recommended up to 20.00 or the SGMO Sept 2018 17 calls for 3 or ...

  • Avatar

    I own a few shares of SGMO, along with CRSP, EDIT, and NLT, and 16 other micro cap Biogen stocks, and I feel that this i...

  • Avatar

    NOVUS reported the following top five 2015 Q1 hedge fund stock-pickers in the Healthcare sector: RA Cap Management; BB...

  • omcdac1

    Patents by Assignee Sangamo Biosciences, Inc. http://patents.justia.com/assignee/sangamo-biosciences-inc...

  • AC/DC

    Long post alert. Mostly for Doc KSS. I remember Sangamo Biosciences ($SGMO) being discussed earlier w.r.t. BLUE. I was ...

  • SoGiAm

    Leo S - RE: Biotechnology Threads Focus- My point is Leo S Look at the BioTech equities that increased Thursday and Frid...

  • Avatar

    The following info about RA Capital's holdings, as at end of 2013 may be of interest to some of you: 37 Positions as of...

  • Avatar

    Hi Booya (maybe you are Cramer) re your reply on March 5th to the original post #10 dated 1/8/2014 on Sangamo Bioscience...

  • Avatar

    SGMO Trading at $23.75ish off a $19.61 close on the news below. Sangamo BioSciences announced the publication in t...

  • Avatar

    I own shares of Sangamo Biosciences (SGMO). Sangamo is focused on the research and commercial development of engineered ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info